Improved targeted nucleotide exchange with LNA modified oligonucleotides

Details for Australian Patent Application No. 2006328054 (hide)

Owner Keygene N.V.

Inventors Wachowski, Ludvik Kevin; Bundock, Paul; De Both, Michiel Theodoor Jan; Hogers, Rene Cornelis Josephus

Agent Baldwins

Pub. Number AU-A-2006328054

PCT Pub. Number WO2007/073170

Priority PCT/ NL2006/000244 09.05.06 NL; PCT/ 22.12.05 NL; NL2005/000884

Filing date 21 December 2006

Wipo publication date 28 June 2007

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/073170 Priority application(s): WO2007/073170

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328064-Anti-gastritis and anti-ulcer agent containing Momordicae semen extract and momordica saponin I isolated from the same

2006328050-Improved targeted nucleotide exchange with propynyl modified oligonucleotides